MEDPLUS Medplus Health Services Q3 FY25 results (Oct–Dec 2024) and concall
Medplus Health Services reported a mixed Q3 FY25, with consolidated revenue growing 8.3% YoY to ₹15,614 million, but experiencing a 0.9% QoQ degrowth. Operating EBITDA stood at 5.1%. The company saw strong performance in its Diagnostics segment, turning profitable with an 8.1% EBITDA margin. While net store additions slowed to 60 in Q3, management is focused on operational efficiency, strengthening back-end infrastructure, and targeting 600+ new stores in FY26.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 156 | 177 |
| EBITDA | 17 | 19 |
| Net profit | 8 | 9 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
